Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5813)
All Articles published online
|
Aug 7, 2012 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Valenti L, Dongiovanni P, Fargion S. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(29): 3782-3786 [PMID: 22876027 DOI: 10.3748/wjg.v18.i29.3782] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i29/3782.htm |
| Number | Citing Articles |
| 1 |
N. Frank, E. M. Tadros. Insulin dysregulation. Equine Veterinary Journal 2014; 46(1): 103 doi: 10.1111/evj.12169
|
| 2 |
Maeva Guillaume, Vlad Ratziu. Pharmacological agents for nonalcoholic steatohepatitis. Hepatology International 2013; 7(S2): 833 doi: 10.1007/s12072-013-9482-8
|
| 3 |
Menezes Nunes. Obesity and Metabolic Syndrome in Children: What’s New?. Endocrinology&Metabolism International Journal 2017; 4(3) doi: 10.15406/emij.2017.04.00090
|
| 4 |
Luca Valenti, Serena Pelusi, Cristiana Bianco, Ferruccio Ceriotti, Alessandra Berzuini, Laura Iogna Prat, Roberta Trotti, Francesco Malvestiti, Roberta D’Ambrosio, Pietro Lampertico, Agostino Colli, Massimo Colombo, Emmanuel A. Tsochatzis, Mirella Fraquelli, Daniele Prati. Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update. Hepatology Communications 2021; 5(11): 1824 doi: 10.1002/hep4.1794
|
| 5 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Iron as a therapeutic target in chronic liver disease. World Journal of Gastroenterology 2023; 29(4): 616-655 doi: 10.3748/wjg.v29.i4.616
|
| 6 |
Nam-Seok Joo, Young-Hwa Choi, Kyung-Jin Yeum, Soo-Jung Park, Beomhee Choi, Young-Sang Kim. Blood Mercury Can Be a Factor of Elevated Serum Ferritin: Analysis of Korea National Health and Nutrition Examination Survey (KNHANES 2008–2012). Biological Trace Element Research 2015; 164(1): 3 doi: 10.1007/s12011-014-0194-2
|
| 7 |
Xiaoying Zhang, Brindha Chelliappan, Rajeswari S, Michael Antonysamy. Recent Advances in Applications of Bioactive Egg Compounds in Nonfood Sectors. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.738993
|
| 8 |
Junfeng Zhang, Jiajia Cao, Hui Xu, Guanping Dong, Ke Huang, Wei Wu, Jingjing Ye, Junfen Fu. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity. Journal of Clinical Laboratory Analysis 2021; 35(2) doi: 10.1002/jcla.23602
|
| 9 |
JUN LIAO, XING XIA, GUO-ZUO WANG, YONG-MEI SHI, JIN-WEN GE. Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia. Molecular Medicine Reports 2015; 11(6): 4047 doi: 10.3892/mmr.2015.3309
|
| 10 |
Eleftheria Makri, Myrsini Orfanidou, Evangelia S. Makri, Antonis Goulas, Evangelos Terpos, Stergios A. Polyzos. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101353 doi: 10.1016/j.jceh.2024.101353
|
| 11 |
Pathik Parikh, Jatin Patel, Meghraj Ingle, Prabha Sawant. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India. Indian Journal of Gastroenterology 2015; 34(3): 200 doi: 10.1007/s12664-015-0572-5
|
| 12 |
Y. Sumida, E. Niki, Y. Naito, T. Yoshikawa. Involvement of free radicals and oxidative stress in NAFLD/NASH. Free Radical Research 2013; 47(11): 869 doi: 10.3109/10715762.2013.837577
|
| 13 |
Luca Valenti, Raffaela Rametta, Paola Dongiovanni, Benedetta M. Motta, Elena Canavesi, Serena Pelusi, Edoardo A. Pulixi, Anna L. Fracanzani, Silvia Fargion, Giovanni Targher. The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease. PLoS ONE 2012; 7(11): e48804 doi: 10.1371/journal.pone.0048804
|
| 14 |
George BB Goh, Danny Issa, Rocio Lopez, Srinivasan Dasarathy, Jaividhya Dasarathy, Ruth Sargent, Carol Hawkins, Rish K Pai, Lisa Yerian, Amer Khiyami, Mangesh R Pagadala, Achuthan Sourianarayanane, Naim Alkhouri, Arthur J McCullough. The development of a non‐invasive model to predict the presence of non‐alcoholic steatohepatitis in patients with non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2016; 31(5): 995 doi: 10.1111/jgh.13235
|
| 15 |
Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan. The Wide and Complex Field of NAFLD Biomarker Research: Trends. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/846923
|
| 16 |
Holly N. Wilkinson, Sophie E. Upson, Kayleigh L. Banyard, Robert Knight, Kimberly A. Mace, Matthew J. Hardman. Reduced Iron in Diabetic Wounds: An Oxidative Stress-Dependent Role for STEAP3 in Extracellular Matrix Deposition and Remodeling. Journal of Investigative Dermatology 2019; 139(11): 2368 doi: 10.1016/j.jid.2019.05.014
|
| 17 |
Münevver Demir, Sonja Lang, Hans‐Michael Steffen. Nonalcoholic fatty liver disease – current status and future directions. Journal of Digestive Diseases 2015; 16(10): 541 doi: 10.1111/1751-2980.12291
|
| 18 |
Raffaelle K Barros, Helma Pinchemel Cotrim, Carla H Daltro, Yanaihara A Oliveira. Hyperferritinemia in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2017; 63(3): 284 doi: 10.1590/1806-9282.63.03.284
|
| 19 |
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
|
| 20 |
Philipp Bernhardt, Wolfgang Kratzer, Julian Schmidberger, Tilmann Graeter, Beate Gruener. Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis. BMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3212-1
|
| 21 |
Elena Corradini, Elena Buzzetti, Paola Dongiovanni, Stefania Scarlini, Angela Caleffi, Serena Pelusi, Isabella Bernardis, Paolo Ventura, Raffaela Rametta, Elena Tenedini, Enrico Tagliafico, Anna Ludovica Fracanzani, Silvia Fargion, Antonello Pietrangelo, Luca Vittorio Valenti. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. Journal of Hepatology 2021; 75(3): 506 doi: 10.1016/j.jhep.2021.03.014
|
| 22 |
Bu B. Yeap, Mark L. Divitini, Jenny E. Gunton, John K. Olynyk, John P. Beilby, Brendan McQuillan, Joseph Hung, Matthew W. Knuiman. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clinical Endocrinology 2015; 82(4): 525 doi: 10.1111/cen.12529
|
| 23 |
Shui-Xian Du, Lin-Lin Lu, Ning Geng, David W. Victor, Li-Zhen Chen, Cong Wang, Hai-Yan Yue, Yong-Ning Xin, Shi-Ying Xuan, Wen-wen Jin. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0613-4
|
| 24 |
Ji Hoon Na, So Won Park, Yunkoo Kang, Hong Koh, Seung Kim. The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease. Pediatric Gastroenterology, Hepatology & Nutrition 2014; 17(4): 248 doi: 10.5223/pghn.2014.17.4.248
|
| 25 |
Chaofeng Wu, Junjie Li, Hui Jia, Jiamin Zhao, Mengchen Qin, Hao Shi, Chang Liu, Jiajie Lin, Min Cai, Yong Gu, Bin Liu, Lei Gao. Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis. Journal of Gastroenterology 2024; 59(4): 342 doi: 10.1007/s00535-024-02082-2
|
| 26 |
M. Shann Wilson, Erik W. Thompson. Venesection is an effective non-pharmacological treatment for patients with high serum ferritin type 2 diabetes. Journal of Clinical and Translational Endocrinology: Case Reports 2017; 3: 1 doi: 10.1016/j.jecr.2016.10.002
|
| 27 |
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
|
| 28 |
Long-Xia Li, Fang-Fang Guo, Hong Liu, Tao Zeng. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets. Cellular and Molecular Life Sciences 2022; 79(4) doi: 10.1007/s00018-022-04239-9
|
| 29 |
Homayoon BASHIRI, Arezoo BOZORGOMID, Vahid SHOJAEIMOTLAGH. Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial. TURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2): 354 doi: 10.3906/sag-1907-82
|
| 30 |
Kai Yang, Ying Pan, Lei Jin, Furong Yu, Fasu Zhang. Low Serum Soluble Transferrin Receptor Levels Are Associated with Poor Prognosis in Patients with Hepatitis B Virus–Related Acute-on-Chronic Liver Failure. Biological Trace Element Research 2023; 201(6): 2757 doi: 10.1007/s12011-022-03385-2
|
| 31 |
Hanqing Chen. Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target. Liver Research 2022; 6(4): 203 doi: 10.1016/j.livres.2022.09.003
|